Bronchial Diseases
Information
- Disease name
- Bronchial Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04222972 | Active, not recruiting | Phase 3 | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | July 24, 2020 | June 30, 2025 |
| NCT00932802 | Completed | Greatest International Antiinfective Trial With Avelox | February 2004 | November 2007 | |
| NCT00989521 | Completed | Phase 1 | Effect of PUR003 on Asthma | December 2009 | October 2011 |
| NCT01264055 | Completed | Cross-sectional Characterization of Idiopathic Bronchiectasis | April 26, 2011 | ||
| NCT02162576 | Completed | N/A | Asthma Data Innovation Demonstration Project | June 2012 | January 2014 |
| NCT03688074 | Completed | Phase 2 | Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) | November 2, 2018 | November 16, 2020 |
| NCT06307379 | Recruiting | Patient Reported Outcome and Experience Measures for Bronchoscopic Procedures | February 13, 2024 | December 30, 2025 | |
| NCT06272370 | Recruiting | Phase 4 | Individualizing Treatment for Asthma in Primary Care | February 1, 2024 | September 30, 2024 |
| NCT04697446 | Unknown status | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC | December 1, 2020 | October 31, 2021 | |
| NCT04319705 | Unknown status | Phase 4 | Anti-viral Effects of Azithromycin in Patients With Asthma and COPD | March 2, 2020 | December 31, 2022 |
| NCT00830427 | Withdrawn | Phase 2 | A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects | April 15, 2009 | December 31, 2009 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001982